

Biography
Dr. Skinner has received a number of awards including a Stop Cancer career development award, numerous teaching awards and listing in “Best Doctors” for over a decade. Her primary focus has been in the surgical treatment of locally advanced bladder cancer and is a nationally recognized expert in bladder reconstruction and continent urinary diversion. She has active ongoing clinical trials in the treatment of bladder cancer and other urologic malignancies.
Professional Summary
Professional Education
- Medical Education: University of Southern California Keck School of Medicine (1983) CA
- Board Certification: American Board of Urology, Urology (1992)
- Residency: USC/LAC Medical Center (1988) CA
- Fellowship: USC Norris Comprehensive Cancer Center (1990) CA
- Internship: USC/LAC Medical Center (1984) CA
- Board Certification, American Board of Urology, Urology (1992)
- Fellowship, USC Norris Comprehensive Cancer Center, Urologic Oncology (1990)
- Residency, LAC+USC Medical Center, Urology (1988)
- Internship, LAC+USC Medical Center, General Surgery (1984)
- Medical Education, Keck USC School of Medicine, Medicine (1983)
- AB, Stanford Universtiy, Human Biology (1976)
Honors & Awards
- Alpha Omega Alpha, USC School of Medicine (1982)
- Faculty Teacher of the Year, USC Department of Urology (1991, 1994, 1997, 2005)
- Janet M. Glasgow Award for Academic Excellence, USC School of Medicine (1983)
- Outstanding Teacher Award, Keck USC School of Medicine (1997, 98, 2000, 02, 03, 06, 11)
- Phi Beta Kappa, Stanford University (1976)
Administrative Appointments
- Chair, Department of Urology (2012 - Present)
Publications
-
Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, or cutaneous or urethral Kock pouch
Hart, S., Skinner, E. C., Meyerowitz, B. E., Boyd, S., Lieskovsky, G., & Skinner, D. G. (1999). Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, or cutaneous or urethral Kock pouch. JOURNAL OF UROLOGY, 162(1), 77–81. -
Quality of life with reconstruction.
Skinner, E. C. (2001). Quality of life with reconstruction. Seminars in Urologic Oncology, 19(1), 56–58. -
Sexuality and intimacy following radical prostatectomy: Patient and partner perspectives
Perez, M. A., Skinner, E. C., & Meyerowitz, B. E. (2002). Sexuality and intimacy following radical prostatectomy: Patient and partner perspectives. HEALTH PSYCHOLOGY, 21(3), 288–293. -
High-risk localized prostate cancer: primary surgery and adjuvant therapy
Skinner, E. C., & Glode, L. M. (2003). High-risk localized prostate cancer: primary surgery and adjuvant therapy. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 21(3), 219–227. -
Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder
Daneshmand, S., Stein, J. P., Lesser, T., Quek, M. L., Nichols, P. W., Miranda, G., … Skinner, D. G. (2004). Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder. JOURNAL OF UROLOGY, 172(1), 81–84. -
Pubovaginal slings for stress urinary incontinence following radical cystectomy and orthotopic neobladder reconstruction in women
Quek, M. L., Ginsberg, D. A., Wilson, S., Skinner, E. C., Stein, J. P., & Skinner, D. G. (2004). Pubovaginal slings for stress urinary incontinence following radical cystectomy and orthotopic neobladder reconstruction in women. JOURNAL OF UROLOGY, 172(1), 219–221. -
Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: Long-term results
Daneshmand, S., Quek, M. L., Stein, J. P., Lieskovsky, G., Cai, J., Pinski, J., … Skinner, D. G. (2004). Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: Long-term results. JOURNAL OF UROLOGY, 172(6), 2252–2255. -
Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy
Quek, M. L., Stein, J. P., Nichols, P. W., Cai, J., Miranda, G., Groshen, S., … Skinner, D. G. (2005). Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. JOURNAL OF UROLOGY, 174(1), 103–106. -
Quality of life after cystectomy and urinary diversion: An evidence based analysis
Gerharz, E. W., Mansson, A., Hunt, S., Skinner, E. C., & Mansson, W. (2005). Quality of life after cystectomy and urinary diversion: An evidence based analysis. JOURNAL OF UROLOGY, 174(5), 1729–1736. -
A critical analysis of perioperative mortality from radical cystectomy
Quek, M. L., Stein, J. P., Daneshmand, S., Miranda, G., Thangathurai, D., Roffey, P., … Skinner, D. G. (2006). A critical analysis of perioperative mortality from radical cystectomy. JOURNAL OF UROLOGY, 175(3), 886–889. -
Surgical benchmarks for the treatment of invasive bladder cancer
Skinner, E. C., Stein, J. P., & Skinner, D. G. (2007). Surgical benchmarks for the treatment of invasive bladder cancer. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 25(1), 66–71. -
Radical cystectomy with extended lymphadenectomy: Evaluating separate package versus en bloc submission for node positive bladder cancer
Stein, J. P., Penson, D. F., Cai, J., Miranda, G., Skinner, E. C., Dunn, M. A., … Skinner, D. G. (2007). Radical cystectomy with extended lymphadenectomy: Evaluating separate package versus en bloc submission for node positive bladder cancer. JOURNAL OF UROLOGY, 177(3), 876–881. -
Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update
Hall, M. C., Chang, S. S., Dalbagni, G., Pruthi, R. S., Seigne, J. D., Skinner, E. C., … Schellhammer, P. F. (2007). Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update. JOURNAL OF UROLOGY, 178(6), 2314–2330. -
The best treatment for high-grade T1 bladder cancer is cystectomy
Skinner, E. C. (2007). The best treatment for high-grade T1 bladder cancer is cystectomy. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 25(6), 523–25. -
Does reflux in orthotopic diversion matter? A randomized prospective comparison of the Studer and T-pouch ileal neobladders
Skinner, E. C., & Skinner, D. G. (2009). Does reflux in orthotopic diversion matter? A randomized prospective comparison of the Studer and T-pouch ileal neobladders. WORLD JOURNAL OF UROLOGY, 27(1), 51–55. -
Extended lymphadenectomy in bladder cancer
Dorin, R. P., & Skinner, E. C. (2010). Extended lymphadenectomy in bladder cancer. CURRENT OPINION IN UROLOGY, 20(5), 414–20. -
Early Complications of Cystectomy After High Dose Pelvic Radiation
Eisenberg, M. S., Dorin, R. P., Bartsch, G., Cai, J., Miranda, G., & Skinner, E. C. (2010). Early Complications of Cystectomy After High Dose Pelvic Radiation. JOURNAL OF UROLOGY, 184(6), 2264–2269. -
Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort
Svatek, R. S., Shariat, S. F., Novara, G., Skinner, E. C., Fradet, Y., Bastian, P. J., … Dinney, C. P. (2011). Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort. BJU INTERNATIONAL, 107(6), 898–904. -
Choosing the right urinary diversion: Patient's choice or surgeon's inclination?
Skinner, E. C. (2011). Choosing the right urinary diversion: Patient's choice or surgeon's inclination? UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 29(5), 473–475. -
Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder.
Kassouf, W., Svatek, R. S., Shariat, S. F., Novara, G., Lerner, S. P., Fradet, Y., … Skinner, E. C. (2013). Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder. Urologic Oncology, 31(4), 480–86. -
Heterogenous effect of androgen receptor CAG tract length on testicular germ cell tumor risk: shorter repeats associated with seminoma but not other histologic types
Davis-Dao, C. A., Siegmund, K. D., Vandenberg, D. J., Skinner, E. C., Coetzee, G. A., Thomas, D. C., … Cortessis, V. K. (2011). Heterogenous effect of androgen receptor CAG tract length on testicular germ cell tumor risk: shorter repeats associated with seminoma but not other histologic types. CARCINOGENESIS, 32(8), 1238–43. -
Factors influencing post-recurrence survival in bladder cancer following radical cystectomy
Mitra, A. P., Quinn, D. I., Dorff, T. B., Skinner, E. C., Schuckman, A. K., Miranda, G., … Daneshmand, S. (2012). Factors influencing post-recurrence survival in bladder cancer following radical cystectomy. BJU INTERNATIONAL, 109(6), 846–854. -
Super Extended Versus Extended Pelvic Lymph Node Dissection in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Comparative Study
Zehnder, P., Studer, U. E., Skinner, E. C., Dorin, R. P., Cai, J., Roth, B., … Skinner, D. G. (2011). Super Extended Versus Extended Pelvic Lymph Node Dissection in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Comparative Study. JOURNAL OF UROLOGY, 186(4), 1261–1268. -
Robotic and Laparoscopic High Extended Pelvic Lymph Node Dissection During Radical Cystectomy: Technique and Outcomes
Desai, M. M., Berger, A. K., Brandina, R. R., Zehnder, P., Simmons, M., Aron, M., … Gill, I. S. (2012). Robotic and Laparoscopic High Extended Pelvic Lymph Node Dissection During Radical Cystectomy: Technique and Outcomes. EUROPEAN UROLOGY, 61(2), 350–355. -
Radical cystectomy with orthotopic neobladder reconstruction following prior radical prostatectomy
Huang, E. Y.-H., Skinner, E. C., Boyd, S. D., Cai, J., Miranda, G., & Daneshmand, S. (2012). Radical cystectomy with orthotopic neobladder reconstruction following prior radical prostatectomy. WORLD JOURNAL OF UROLOGY, 30(6), 741–745. -
Critical Evaluation of the American Joint Committee on Cancer TNM Nodal Staging System in Patients with Lymph Node-Positive Disease after Radical Cystectomy
Bruins, H. M., Dorin, R. P., Rubino, B., Miranda, G., Cai, J., Daneshmand, S., & Skinner, E. C. (2012). Critical Evaluation of the American Joint Committee on Cancer TNM Nodal Staging System in Patients with Lymph Node-Positive Disease after Radical Cystectomy. EUROPEAN UROLOGY, 62(4), 671–76. -
SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer and Recurrence after 2 Prior Courses of Intravesical Bacillus Calmette-Guerin
Skinner, E. C., Goldman, B., Sakr, W. A., Petrylak, D. P., Lenz, H.-J., Lee, C. T., … Thompson, I. M. (2013). SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer and Recurrence after 2 Prior Courses of Intravesical Bacillus Calmette-Guerin. JOURNAL OF UROLOGY, 190(4), 1200–1204. -
INDICATIONS FOR LOWER URINARY-TRACT RECONSTRUCTION IN WOMEN AFTER CYSTECTOMY FOR BLADDER-CANCER - A PATHOLOGICAL REVIEW OF FEMALE CYSTECTOMY SPECIMENS
Stein, J. P., Cote, R. J., Freeman, J. A., Esrig, D., Elmajian, D. A., Groshen, S., … Skinner, D. G. (1995). INDICATIONS FOR LOWER URINARY-TRACT RECONSTRUCTION IN WOMEN AFTER CYSTECTOMY FOR BLADDER-CANCER - A PATHOLOGICAL REVIEW OF FEMALE CYSTECTOMY SPECIMENS. JOURNAL OF UROLOGY, 154(4), 1329–1333. -
Complications of the afferent antireflux valve mechanism in the kock ileal reservoir
Stein, J. P., Freeman, J. A., Esrig, D., Elmajian, D. A., Tarter, T. H., Skinner, E. C., … Skinner, D. G. (1996). Complications of the afferent antireflux valve mechanism in the kock ileal reservoir. JOURNAL OF UROLOGY, 155(5), 1579–1583. -
Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion
Esrig, D., Freeman, C. A., Elmajian, D. A., Stein, J. P., Chen, S. C., Groshen, S., … Skinner, D. G. (1996). Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. JOURNAL OF UROLOGY, 156(3), 1071–1076. -
Management of complex urologic injuries
Skinner, E. C., Parisky, Y. R., & Skinner, D. G. (1996). Management of complex urologic injuries. SURGICAL CLINICS OF NORTH AMERICA, 76(4), 861-? -
Orthotopic lower urinary tract reconstruction in women using the kock ileal neobladder: Updated experience in 34 patients
Stein, J. P., Grossfeld, G. D., Freeman, J. A., Esrig, D., Ginsberg, D. A., Cote, R. J., … Skinner, D. G. (1997). Orthotopic lower urinary tract reconstruction in women using the kock ileal neobladder: Updated experience in 34 patients. JOURNAL OF UROLOGY, 158(2), 400–405. -
Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile AIDS
Perez, M. A., Meyerowitz, B. E., Lieskovsky, G., Skinner, D. G., Reynolds, B., & Skinner, E. C. (1997). Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile AIDS. UROLOGY, 50(5), 740–746. -
25-year experience in the management of invasive bladder cancer by radical cystectomy
Skinner, D. G., Stein, J. P., Lieskovsky, G., Skinner, E. C., Boyd, S. D., Figueroa, A., … Groshen, S. (1998). 25-year experience in the management of invasive bladder cancer by radical cystectomy. Presented at the 6th Heinrich Warner Symposium on Invasive Bladder Carcinoma - Progress in Basic Research, Surgical and Medical Therapy, HAMBURG,GERMANY: ELSEVIER SCIENCE BV. -
Radical cystectomy for elderly patients with bladder carcinoma - An updated experience with 404 patients
Figueroa, A. J., Stein, J. P., Dickinson, M., Skinner, E. C., Thangathurai, D., Mikhail, M. S., … Skinner, D. G. (1998). Radical cystectomy for elderly patients with bladder carcinoma - An updated experience with 404 patients. CANCER, 83(1), 141–147. -
The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels
Cote, R. J., Skinner, E. C., Salem, C. E., Mertes, S. J., Stanczyk, F. Z., Henderson, B. E., … Ross, R. K. (1998). The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels. BRITISH JOURNAL OF CANCER, 78(3), 413–418. -
Hydronephrosis as a prognostic indicator in bladder cancer patients
Haleblian, G. E., Skinner, E. C., Dickinson, M. G., Lieskovsky, G., Boyd, S. D., & Skinner, D. G. (1998). Hydronephrosis as a prognostic indicator in bladder cancer patients. JOURNAL OF UROLOGY, 160(6), 2011–2014. -
Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study
Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. (2011). European Urology, 60. -
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy
Shariat, S. F., Svatek, R. S., Tilki, D., Skinner, E., Karakiewicz, P. I., Capitanio, U., … Fradet, Y. (2010). International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU INTERNATIONAL, 105(10), 1402–1412. -
Disease-Free Survival at 2 or 3 Years Correlates With 5-Year Overall Survival of Patients Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer
Sonpavde, G., Khan, M. M., Lerner, S. P., Svatek, R. S., Novara, G., Karakiewicz, P. I., … Shariat, S. F. (2011). Disease-Free Survival at 2 or 3 Years Correlates With 5-Year Overall Survival of Patients Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer. JOURNAL OF UROLOGY, 185(2), 456–461. -
Soft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy: A Multicenter Study of More Than 4,400 Patients
Novara, G., Svatek, R. S., Karakiewicz, P. I., Skinner, E., Ficarra, V., Fradet, Y., … Shariat, S. F. (2010). Soft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy: A Multicenter Study of More Than 4,400 Patients. JOURNAL OF UROLOGY, 183(6), 2165–2170. -
DOES THE RACIAL-ETHNIC VARIATION IN PROSTATE-CANCER RISK HAVE A HORMONAL BASIS
Ross, R. K., Coetzee, G. A., Reichardt, J., Skinner, E., & Henderson, B. E. (1995). DOES THE RACIAL-ETHNIC VARIATION IN PROSTATE-CANCER RISK HAVE A HORMONAL BASIS. CANCER, 75(7), 1778–1782. -
Alterations in circulating levels of androgens and PSA during treatment with finasteride in men at high risk for prostate cancer
Stanczyk, F. Z., Skinner, E. C., Mertes, S., Spahn, M. F., Lobo, R. A., & Ross, R. K. (1996). Alterations in circulating levels of androgens and PSA during treatment with finasteride in men at high risk for prostate cancer. Presented at the 2nd International Hormonal Carcinogenesis Symposium, STOCKHOLM,SWEDEN: SPRINGER-VERLAG. -
Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort
Fritsche, H.-M., Burger, M., Svatek, R. S., Jeldres, C., Karakiewicz, P. I., Novara, G., … Shariat, S. F. (2010). Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort. EUROPEAN UROLOGY, 57(2), 300–309. -
Validation of the AJCC TNM Substaging of pT2 Bladder Cancer: Deep Muscle Invasion Is Associated with Significantly Worse Outcome
Tilki, D., Reich, O., Karakiewicz, P. I., Novara, G., Kassouf, W., Erguen, S., … Shariat, S. F. (2010). Validation of the AJCC TNM Substaging of pT2 Bladder Cancer: Deep Muscle Invasion Is Associated with Significantly Worse Outcome. EUROPEAN UROLOGY, 58(1), 112–117. -
Characteristics and Outcomes of Patients With Clinical Carcinoma In Situ Only Treated With Radical Cystectomy: An International Study of 243 Patients
Tilki, D., Reich, O., Svatek, R. S., Karakiewicz, P. I., Kassouf, W., Novara, G., … Shariat, S. F. (2010). Characteristics and Outcomes of Patients With Clinical Carcinoma In Situ Only Treated With Radical Cystectomy: An International Study of 243 Patients. JOURNAL OF UROLOGY, 183(5), 1757–1763. -
Stage pT0 at Radical Cystectomy Confers Improved Survival: An International Study of 4,430 Patients
Tilki, D., Svatek, R. S., Novara, G., Seitz, M., Godoy, G., Karakiewicz, P. I., … Shariat, S. F. (2010). Stage pT0 at Radical Cystectomy Confers Improved Survival: An International Study of 4,430 Patients. JOURNAL OF UROLOGY, 184(3), 888–894. -
pT3 Substaging is a Prognostic Indicator for Lymph Node Negative Urothelial Carcinoma of the Bladder
Tilki, D., Svatek, R. S., Karakiewicz, P. I., Novara, G., Seitz, M., Sonpavde, G., … Shariat, S. F. (2010). pT3 Substaging is a Prognostic Indicator for Lymph Node Negative Urothelial Carcinoma of the Bladder. JOURNAL OF UROLOGY, 184(2), 470–474. -
Concomitant Carcinoma in situ in Cystectomy Specimens Is Not Associated with Clinical Outcomes after Surgery
Nuhn, P., Bastian, P. J., Novara, G., Svatek, R. S., Karakiewicz, P. I., Skinner, E., … Shariat, S. F. (2011). Concomitant Carcinoma in situ in Cystectomy Specimens Is Not Associated with Clinical Outcomes after Surgery. UROLOGIA INTERNATIONALIS, 87(1), 42–48. -
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy
Sonpavde, G., Khan, M. M., Svatek, R. S., Lee, R., Novara, G., Tilki, D., … Shariat, S. F. (2011). Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy. BJU INTERNATIONAL, 108(5), 687–92. -
Prognostic Risk Stratification of Pathological Stage T3N0 Bladder Cancer After Radical Cystectomy
Sonpavde, G., Khan, M. M., Svatek, R. S., Lee, R., Novara, G., Tilki, D., … Shariat, S. F. (2011). Prognostic Risk Stratification of Pathological Stage T3N0 Bladder Cancer After Radical Cystectomy. JOURNAL OF UROLOGY, 185(4), 1216–21. -
Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy
Chromecki, T. F., Mauermann, J., Cha, E. K., Svatek, R. S., Fajkovic, H., Karakiewicz, P. I., … Shariat, S. F. (2012). Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy. WORLD JOURNAL OF UROLOGY, 30(6), 753–59. -
Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy
Bruins, H. M., Wopat, R., Mitra, A. P., Cai, J., Miranda, G., Skinner, E. C., & Daneshmand, S. (2013). Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy. BJU INTERNATIONAL, 111(3B), E37–E42. -
URINARY-DIVERSION
Skinner, D. G., Skinner, E. C., Lieskovsky, G., & Boyd, S. D. (1987). URINARY-DIVERSION. CURRENT PROBLEMS IN SURGERY, 24(7), 401–471. -
RADICAL CYSTECTOMY
Skinner, E. C., Lieskovsky, G., & Skinner, D. G. (1991). RADICAL CYSTECTOMY. AKTUELLE UROLOGIE, 22(5), AR1–AR14. -
A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer
Mitra, A. P., Skinner, E. C., Miranda, G., & Daneshmand, S. (2013). A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer. BJU INTERNATIONAL, 111(2), 240–48. -
ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary Diversion
Hautmann, R. E., Abol-Enein, H., Davidsson, T., Gudjonsson, S., Hautmann, S. H., Holm, H. V., … Xu, A. (2013). ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary Diversion. EUROPEAN UROLOGY, 63(1), 67–80. -
RADICAL CYSTECTOMY IN REGIONALLY ADVANCED BLADDER-CANCER
Lerner, S. P., Skinner, E., & Skinner, D. G. (1992). RADICAL CYSTECTOMY IN REGIONALLY ADVANCED BLADDER-CANCER. UROLOGIC CLINICS OF NORTH AMERICA, 19(4), 713–723. -
Continent and orthotopic urinary diversion following radical cystectomy. Should these reconstructive procedures now be considered standard of care?
Boyd, S. D., Skinner, E., Lieskovsky, G., & Skinner, D. G. (1995). Continent and orthotopic urinary diversion following radical cystectomy. Should these reconstructive procedures now be considered standard of care? Surgical Oncology Clinics of North America, 4(2), 277–286. -
Incidental Prostate Cancer in Patients with Bladder Urothelial Carcinoma: Comprehensive Analysis of 1,476 Radical Cystoprostatectomy Specimens
Bruins, H. M., Djaladat, H., Ahmadi, H., Sherrod, A., Cai, J., Miranda, G., … Daneshmand, S. (2013). Incidental Prostate Cancer in Patients with Bladder Urothelial Carcinoma: Comprehensive Analysis of 1,476 Radical Cystoprostatectomy Specimens. JOURNAL OF UROLOGY, 190(5), 1704–9. -
Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients
Stein, J. P., Lieskovsky, G., Cote, R., Groshen, S., Feng, A. C., Boyd, S., … Skinner, D. G. (2001). Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. JOURNAL OF CLINICAL ONCOLOGY, 19(3), 666–675. -
Combination of Molecular Alterations and Smoking Intensity Predicts Bladder Cancer Outcome A Report From the Los Angeles Cancer Surveillance Program
Mitra, A. P., Castelao, J. E., Hawes, D., Tsao-Wei, D. D., Jiang, X., Shi, S.-R., … Cote, R. J. (2013). Combination of Molecular Alterations and Smoking Intensity Predicts Bladder Cancer Outcome A Report From the Los Angeles Cancer Surveillance Program. CANCER, 119(4), 756–765. -
Functional heterogeneity of prostatic intraepithelial neoplasia: the duration of hormonal therapy influences the response
Kang, T. Y., Nichols, P., Skinner, E., Groshen, S., Valin, G., Ye, W., & Raghavan, D. (2007). Functional heterogeneity of prostatic intraepithelial neoplasia: the duration of hormonal therapy influences the response. BJU INTERNATIONAL, 99(5), 1024–1027. -
Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy.
Bruins, H. M., Wopat, R., Mitra, A. P., Cai, J., Miranda, G., Skinner, E. C., & Daneshmand, S. (2013). Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy. BJU International, 111(3), E37–42. -
XANTHOGRANULOMATOUS PYELONEPHRITIS - CLINICAL FINDINGS AND SURGICAL CONSIDERATIONS
Eastham, J., Ahlering, T., & Skinner, E. (1994). XANTHOGRANULOMATOUS PYELONEPHRITIS - CLINICAL FINDINGS AND SURGICAL CONSIDERATIONS. UROLOGY, 43(3), 295–299. -
Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades
Zehnder, P., Studer, U. E., Skinner, E. C., Thalmann, G. N., Miranda, G., Roth, B., … Gill, I. S. (2013). Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades. BJU INTERNATIONAL, 112(2), E51–E58. -
Prevention of prostate cancer with finasteride.
Ross, R. K., Skinner, E., & Cote, R. J. (2003). Prevention of prostate cancer with finasteride. New England Journal of Medicine, 349(16), 1569–1572. -
Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: A retrospective analysis from the University of Southern California
Fairey, A. S., Daneshmand, S., Quinn, D., Dorff, T., Dorin, R., Lieskovsky, G., … Skinner, E. C. (2013). Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: A retrospective analysis from the University of Southern California. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 31(8), 1737–43. -
A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urine
Birkhahn, M., Mitra, A. P., Williams, A. J., Barr, N. J., Skinner, E. C., Stein, J. P., … Cote, R. J. (2013). A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urine. EUROPEAN JOURNAL OF CANCER, 49(15), 3159–68. -
THE RATIONALE FOR EN-BLOC PELVIC LYMPH-NODE DISSECTION FOR BLADDER-CANCER PATIENTS WITH NODAL METASTASES - LONG-TERM RESULTS
Lerner, S. P., Skinner, D. G., Lieskovsky, G., Boyd, S. D., Groshen, S. L., Ziogas, A., … Hopwood, B. (1993). THE RATIONALE FOR EN-BLOC PELVIC LYMPH-NODE DISSECTION FOR BLADDER-CANCER PATIENTS WITH NODAL METASTASES - LONG-TERM RESULTS. JOURNAL OF UROLOGY, 149(4), 758–765. -
Urinary Functional Outcome Following Radical Cystoprostatectomy and Ileal Neobladder Reconstruction in Male Patients
Ahmadi, H., Skinner, E. C., Simma-Chiang, V., Miranda, G., Cai, J., Penson, D. F., & Daneshmand, S. (2013). Urinary Functional Outcome Following Radical Cystoprostatectomy and Ileal Neobladder Reconstruction in Male Patients. JOURNAL OF UROLOGY, 189(5), 1782–88. -
Reproductive Organ Involvement in Female Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer
Djaladat, H., Bruins, H. M., Miranda, G., Cai, J., Skinner, E. C., & Daneshmand, S. (2012). Reproductive Organ Involvement in Female Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer. JOURNAL OF UROLOGY, 188(6), 2134–2138. -
Null Association Between Histology of First and Second Primary Malignancies in Men With Bilateral Testicular Germ Cell Tumors
Thomas, J. P. J., Davis-Dao, C., Lewinger, J. P., Siegmund, K. D., Hamilton, A. S., Daneshmand, S., … Cortessis, V. K. (2013). Null Association Between Histology of First and Second Primary Malignancies in Men With Bilateral Testicular Germ Cell Tumors. AMERICAN JOURNAL OF EPIDEMIOLOGY, 178(8), 1240–45. -
Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping study.
Bruins, H. M., Skinner, E. C., Dorin, R. P., Ahmadi, H., Djaladat, H., Miranda, G., … Daneshmand, S. (2014). Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping study. Urologic Oncology, 32(1), 24 e13–9. -
Radical cystectomy and orthotopic urinary diversion in male patients with pT4a urothelial bladder carcinoma: Oncological outcomes
Djaladat, H., Mitra, A. P., Miranda, G., Skinner, E. C., & Daneshmand, S. (2013). Radical cystectomy and orthotopic urinary diversion in male patients with pT4a urothelial bladder carcinoma: Oncological outcomes. INTERNATIONAL JOURNAL OF UROLOGY, 20(12), 1229–33. -
Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients.
Mitra, A. P., Skinner, E. C., Schuckman, A. K., Quinn, D. I., Dorff, T. B., & Daneshmand, S. (2014). Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients. Urologic Oncology, 32(1), 52 e1–9. -
Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era.
Fairey, A. S., Daneshmand, S., Skinner, E. C., Schuckman, A., Cai, J., & Lieskovsky, G. (2014). Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era. Urologic Oncology, 32(2), 85–91. -
Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy.
Fairey, A. S., Daneshmand, S., Wang, L., Schuckman, A., Lieskovsky, G., Djaladat, H., … Skinner, E. C. (2014). Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy. Urologic Oncology, 32(2), 110–16. -
Urinary functional outcomes in female neobladder patients.
Bartsch, G., Daneshmand, S., Skinner, E. C., Syan, S., Skinner, D. G., & Penson, D. F. (2014). Urinary functional outcomes in female neobladder patients. World Journal of Urology, 32(1), 221–28. -
Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis.
Messer, J. C., Shariat, S. F., Dinney, C. P., Novara, G., Fradet, Y., Kassouf, W., … Svatek, R. S. (2014). Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis. Urology, 83(4), 863–68. -
Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy
Zehnder, P., Studer, U. E., Daneshmand, S., Birkhaeuser, F. D., Skinner, E. C., Roth, B., … Gill, I. S. (2014). Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy. BJU INTERNATIONAL, 113(4), 554–560. -
The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer.
Djaladat, H., Bruins, H. M., Miranda, G., Cai, J., Skinner, E. C., & Daneshmand, S. (2014). The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer. BJU International, 113(6), 887–93. -
Comprehensive molecular characterization of urothelial bladder carcinoma
Weinstein, J. N., Akbani, R., Broom, B. M., Wang, W., Verhaak, R. G. W., McConkey, D., … Eley, G. (2014). Comprehensive molecular characterization of urothelial bladder carcinoma. NATURE, 507(7492), 315–22. -
Is extended lymphadenectomy of beneficial therapeutic value for T2 urothelial cancer?
Skinner, E. C., & Sagalowsky, A. I. (2014). Is extended lymphadenectomy of beneficial therapeutic value for T2 urothelial cancer? Journal of Urology, 191(5), 1206–8. -
Level III-IV Inferior Vena Caval Thrombectomy Without Cardiopulmonary Bypass: Long-Term Experience with Intrapericardial Control
Patil, M. B., Montez, J., Loh-Doyle, J., Cai, J., Skinner, E. C., Schuckman, A., … Daneshmand, S. (2014). Level III-IV Inferior Vena Caval Thrombectomy Without Cardiopulmonary Bypass: Long-Term Experience with Intrapericardial Control. JOURNAL OF UROLOGY, 192(3), 682–88. -
Endoscopic molecular imaging of human bladder cancer using a CD47 antibody.
Pan, Y., Volkmer, J.-P., Mach, K. E., Rouse, R. V., Liu, J.-J., Sahoo, D., … Liao, J. C. (2014). Endoscopic molecular imaging of human bladder cancer using a CD47 antibody. Science Translational Medicine, 6(260), 260ra148-? -
Endoscopic molecular imaging of human bladder cancer using a CD47 antibody
Pan, Y., Volkmer, J.-P., Mach, K. E., Rouse, R. V., Liu, J.-J., Sahoo, D., … Liao, J. C. (2014). Endoscopic molecular imaging of human bladder cancer using a CD47 antibody. SCIENCE TRANSLATIONAL MEDICINE, 6(260). -
Outcomes After Urothelial Recurrence in Bladder Cancer Patients Undergoing Radical Cystectomy
Mitra, A. P., Alemozaffar, M., Harris, B. N., Schuckman, A. K., Skinner, E. C., & Daneshmand, S. (2014). Outcomes After Urothelial Recurrence in Bladder Cancer Patients Undergoing Radical Cystectomy. UROLOGY, 84(6). -
Genitourinary cancer in the elderly
Raghavan, D., & Skinner, E. (2004). Genitourinary cancer in the elderly. SEMINARS IN ONCOLOGY, 31(2), 249–263. -
Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy.
Zehnder, P., Moltzahn, F., Daneshmand, S., Leahy, M., Cai, J., Miranda, G., … Gill, I. S. (2014). Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy. BJU International, 113(1), 65–69. -
Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis
Mitra, A. P., Bartsch, C. C., Bartsch, G., Miranda, G., Skinner, E. C., & Daneshmand, S. (2014). Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 32(2), 117–27. -
A Panel of Three Markers Hyper- and Hypomethylated in Urine Sediments Accurately Predicts Bladder Cancer Recurrence
Su, S.-F., Abreu, A. L. de C., Chihara, Y., Tsai, Y., Andreu-Vieyra, C., Daneshmand, S., … Liang, G. (2014). A Panel of Three Markers Hyper- and Hypomethylated in Urine Sediments Accurately Predicts Bladder Cancer Recurrence. CLINICAL CANCER RESEARCH, 20(7), 1978–89. -
Urinary Diversion: How Experts Divert
Hautmann, R. E., Abol-Enein, H., Lee, C. T., Mansson, W., Mills, R. D., Penson, D. F., … Volkmer, B. G. (2015). Urinary Diversion: How Experts Divert. UROLOGY, 85(1), 233–38. -
Best Practices in Robot-assisted Radical Cystectomy and Urinary Reconstruction: Recommendations of the Pasadena Consensus Panel
Wilson, T. G., Guru, K., Rosen, R. C., Wiklund, P., Annerstedt, M., Bochner, B. H., … Catto, J. (2015). Best Practices in Robot-assisted Radical Cystectomy and Urinary Reconstruction: Recommendations of the Pasadena Consensus Panel. EUROPEAN UROLOGY, 67(3), 363–75. -
A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma
Van Poppel, H., Da Pozzo, L., Albrecht, W., Matveev, V., Bono, A., Borkowski, A., … Sylvester, R. (2007). A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. EUROPEAN UROLOGY, 51(6), 1606–15. -
A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma
Van Poppel, H., Da Pozzo, L., Albrecht, W., Matveev, V., Bono, A., Borkowski, A., … Sylvester, R. (2011). A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma. EUROPEAN UROLOGY, 59(4), 543–52. -
Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23
Schumacher, F. R., Wang, Z., Skotheim, R. I., Koster, R., Chung, C. C., Hildebrandt, M. A. T., … McGlynn, K. A. (2013). Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. HUMAN MOLECULAR GENETICS, 22(13), 2748–53. -
Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer
Mitra, A. P., Lam, L. L., Ghadessi, M., Erho, N., Vergara, I. A., Alshalalfa, M., … Black, P. C. (2014). Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 106(11). -
Meta-analysis identifies four new loci associated with testicular germ cell tumor
Chung, C. C., Kanetsky, P. A., Wang, Z., Hildebrandt, M. A. T., Koster, R., Skotheim, R. I., … Nathanson, K. L. (2013). Meta-analysis identifies four new loci associated with testicular germ cell tumor. NATURE GENETICS, 45(6), 680-? -
Reprogramming of the human intestinal epigenome by surgical tissue transposition
Lay, F. D., Triche, T. J., Tsai, Y. C., Su, S.-F., Martin, S. E., Daneshmand, S., … Jones, P. A. (2014). Reprogramming of the human intestinal epigenome by surgical tissue transposition. GENOME RESEARCH, 24(4), 545–53. -
Randomized Trial of Studer Pouch versus T-Pouch Orthotopic Ileal Neobladder in Patients with Bladder Cancer
Skinner, E. C., Fairey, A. S., Groshen, S., Daneshmand, S., Cai, J., Miranda, G., & Skinner, D. G. (2015). Randomized Trial of Studer Pouch versus T-Pouch Orthotopic Ileal Neobladder in Patients with Bladder Cancer. JOURNAL OF UROLOGY, 194(2), 433–39. -
Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel.
Wilson, T. G., Guru, K., Rosen, R. C., Wiklund, P., Annerstedt, M., Bochner, B. H., … Catto, J. (2015). Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel. European Urology, 67(3), 363–75. -
Radical cystectomy with super-extended lymphadenectomy: impact of separate vs en bloc lymph node submission on analysis and outcomes
Zehnder, P., Moltzahn, F., Mitra, A. P., Cai, J., Miranda, G., Skinner, E. C., … Daneshmand, S. (2016). Radical cystectomy with super-extended lymphadenectomy: impact of separate vs en bloc lymph node submission on analysis and outcomes. BJU INTERNATIONAL, 117(2), 253–59. -
Continent cutaneous diversion
Skinner, E. C. (2015). Continent cutaneous diversion. CURRENT OPINION IN UROLOGY, 25(6), 555–61. -
Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures.
Seiler, R., Lam, L. L., Erho, N., Takhar, M., Mitra, A. P., Buerki, C., … Black, P. C. (2016). Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures. Journal of Urology, 196(4), 1036–41. -
Contemporary Use of Partial Nephrectomy: Are Older Patients With Impaired Kidney Function Being Left Behind?
Leppert, J. T., Mittakanti, H. R., Thomas, I.-C., Lamberts, R. W., Sonn, G. A., Chung, B. I., … Brooks, J. D. (2016). Contemporary Use of Partial Nephrectomy: Are Older Patients With Impaired Kidney Function Being Left Behind? Urology. -
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
Chang, S. S., Boorjian, S. A., Chou, R., Clark, P. E., Daneshmand, S., Konety, B. R., … McKiernan, J. M. (2016). Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline. JOURNAL OF UROLOGY, 196(4), 1021–29. -
Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer.
Dorff, T. B., Schuckman, A. K., Schwartz, R., Rashad, S., Bulbul, A., Cai, J., … Quinn, D. I. (2016). Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer. Clinical Genitourinary Cancer, 14(5), 450–56 e1. -
Reconstruction With Pedicled Anterolateral Thigh Flap After Wide Local Excision of Penoscrotal Extramammary Paget's Disease: A Case Report and Comprehensive Literature Review.
Hunter, C. L., Skinner, E. C., & Lee, G. K. (2015). Reconstruction With Pedicled Anterolateral Thigh Flap After Wide Local Excision of Penoscrotal Extramammary Paget's Disease: A Case Report and Comprehensive Literature Review. Eplasty, 15. -
Contemporary Use of Partial Nephrectomy: Are Older Patients With Impaired Kidney Function Being Left Behind?
Leppert, J. T., Mittakanti, H. R., Thomas, I.-C., Lamberts, R. W., Sonn, G. A., Chung, B. I., … Brooks, J. D. (2017). Contemporary Use of Partial Nephrectomy: Are Older Patients With Impaired Kidney Function Being Left Behind? UROLOGY, 100, 65–71. -
Consolidative Radiotherapy in Metastatic Urothelial Cancer.
Shah, S., Zhang, C. A., Hancock, S., Fan, A., Skinner, E., & Srinivas, S. (2017). Consolidative Radiotherapy in Metastatic Urothelial Cancer. Clinical Genitourinary Cancer. -
Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center
Porter, J. B. (2017). Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center. Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center, 13(8), e673–e682. -
Incident CKD after Radical or Partial Nephrectomy.
Leppert, J. T., Lamberts, R. W., Thomas, I.-C. C., Chung, B. I., Sonn, G. A., Skinner, E. C., … Brooks, J. D. (2017). Incident CKD after Radical or Partial Nephrectomy. Journal of the American Society of Nephrology : JASN. -
Consolidative radiotherapy in metastatic urothelial cancer (MUC)
Srinivas, S., Narayanan, S., Fan, A. C., Hancock, S. L., & Skinner, E. C. (2016). Consolidative radiotherapy in metastatic urothelial cancer (MUC). JOURNAL OF CLINICAL ONCOLOGY, 34(2). -
Orthotopic Urinary Diversion for Women
Zlatev, D. V., & Skinner, E. C. (2018). Orthotopic Urinary Diversion for Women. UROLOGIC CLINICS OF NORTH AMERICA, 45(1), 49-+. -
Immunotherapy in Urothelial Cancer, Part 1: T-Cell Checkpoint Inhibition in Advanced or Metastatic Disease
Yu, S. S., Dorff, T. B., Ballas, L. K., Sadeghi, S., Skinner, E. C., & Quinn, D. I. (2017). Immunotherapy in Urothelial Cancer, Part 1: T-Cell Checkpoint Inhibition in Advanced or Metastatic Disease. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 15(6), 466–77. -
Immunotherapy in Urothelial Cancer, Part 2: Adjuvant, Neoadjuvant, and Adjunctive Treatment
Yu, S. S., Ballas, L. K., Skinner, E. C., Dorff, T. B., Sadeghi, S., & Quinn, D. I. (2017). Immunotherapy in Urothelial Cancer, Part 2: Adjuvant, Neoadjuvant, and Adjunctive Treatment. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 15(7), 543–51. -
Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer
Harshman, L. C., Tripathi, A., Kaag, M., Efstathiou, J. A., Apolo, A. B., Hoffman-Censits, J. H., … Sridhar, S. S. (2018). Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer. CLINICAL GENITOURINARY CANCER, 16(3), 213–18. -
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
Parekh, D. J., Reis, I. M., Castle, E. P., Gonzalgo, M. L., Woods, M. E., Svatek, R. S., … Thompson, I. M. (2018). Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. LANCET, 391(10139), 2525–36. -
Readmission Rate and Causes at 90-Day after Radical Cystectomy in Patients on Early Recovery after Surgery Protocol
Altobelli, E., Buscarini, M., Gill, H. S., & Skinner, E. C. (2017). Readmission Rate and Causes at 90-Day after Radical Cystectomy in Patients on Early Recovery after Surgery Protocol. BLADDER CANCER, 3(1), 51–56. -
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma (vol 5, 68, 2017)
Kamat, A. M., Bellmunt, J., Galsky, M. D., Konety, B. R., Lamm, D. L., Langham, D., … Rosenberg, J. E. (2017). Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma (vol 5, 68, 2017). JOURNAL FOR IMMUNOTHERAPY OF CANCER, 5, 80. -
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
Kamat, A. M., Bellmunt, J., Galsky, M. D., Konety, B. R., Lamm, D. L., Langham, D., … Rosenberg, J. E. (2017). Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 5, 68. -
Can We Improve the Functional Outcomes of Orthotopic Diversion in Women?
Skinner, E. C., & Comiter, C. V. (2015). Can We Improve the Functional Outcomes of Orthotopic Diversion in Women? EUROPEAN UROLOGY, 68(4), 672–73. -
Exploring multidisciplinary practice patterns in the management of muscle invasive bladder cancer (MIBC) across the US and Canada in 2015.
Harshman, L. C., Kaag, M., Efstathiou, J. A., Apolo, A. B., Hoffman-Censits, J. H., Stadler, W. M., … Sridhar, S. S. (2016). Exploring multidisciplinary practice patterns in the management of muscle invasive bladder cancer (MIBC) across the US and Canada in 2015. JOURNAL OF CLINICAL ONCOLOGY, 34(2). -
Prognostic features for testicular cancers (TCs): Can this be gleaned from pathology reports?
Srinivas, S., Eisenberg, M., & Skinner, E. C. (2015). Prognostic features for testicular cancers (TCs): Can this be gleaned from pathology reports? JOURNAL OF CLINICAL ONCOLOGY, 33(15). -
Development and validation of surgical training tool: cystectomy assessment and surgical evaluation (CASE) for robot-assisted radical cystectomy for men
Hussein, A. A., Sexton, K. J., May, P. R., Meng, M. V., Hosseini, A., Eun, D. D., … Guru, K. A. (2018). Development and validation of surgical training tool: cystectomy assessment and surgical evaluation (CASE) for robot-assisted radical cystectomy for men. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 32(11), 4458–64. -
Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation.
Mitra, A. P., Fairey, A. S., Skinner, E. C., Boorjian, S. A., Frank, I., Schoenberg, M. P., … Daneshmand, S. (2018). Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation. Urologic Oncology. -
Giant renal angiomyolipoma in a solitary kidney.
Sohlberg, E., Sun, A., Massoudi, R., Prado, K., & Skinner, E. (2018). Giant renal angiomyolipoma in a solitary kidney. The Canadian Journal of Urology, 25(6), 9614–16. -
Giant renal angiomyolipoma in a solitary kidney
Sohlberg, E., Sun, A., Massoudi, R., Prado, K., & Skinner, E. (2018). Giant renal angiomyolipoma in a solitary kidney. CANADIAN JOURNAL OF UROLOGY, 25(6), 9614–16. -
Treatment of Muscle-Invasive Bladder Cancer in Older Patients.
Skinner, E. C. (2016). Treatment of Muscle-Invasive Bladder Cancer in Older Patients. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, (36), e228–e233. -
Editorial Comment
Skinner, E. C. (2017). Editorial Comment. JOURNAL OF UROLOGY, 198(5), 1106. -
Treatment of Muscle-Invasive Bladder Cancer in Older Patients.
Skinner, E. C. (2016). Treatment of Muscle-Invasive Bladder Cancer in Older Patients. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, 35, e228–33. -
Is 42 days the 'magic number' for repeat transurethral resection of bladder tumour (TURBT)?
Skinner, E. C. (2015). Is 42 days the 'magic number' for repeat transurethral resection of bladder tumour (TURBT)? BJU INTERNATIONAL, 116(5), 678–79. -
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial.
Parekh, D. J., Reis, I. M., Castle, E. P., Gonzalgo, M. L., Woods, M. E., Svatek, R. S., … Thompson, I. M. (2018). Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet (London, England), 391(10139), 2525–2536. -
Improving care with portfolio of physician-led cancer quality measures at an academic center
Porter, J., Smith, A. S., Winget, M., Rosenthal, E. L., Seshadri, S. B., Vetteth, Y., … Blayney, D. W. (2017). Improving care with portfolio of physician-led cancer quality measures at an academic center. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY. -
Preparing for bundled payments in urology: Defining episodes, evaluating variations in care, and demonstrating improved value.
Skinner, E. C., Tang, N., Stevenson, K., Guo, D., Hu, J.-S., Hendershott, J., & Krishna, P. (2017). Preparing for bundled payments in urology: Defining episodes, evaluating variations in care, and demonstrating improved value. JOURNAL OF CLINICAL ONCOLOGY, 35(8). -
Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation
Mitra, A. P., Fairey, A. S., Skinner, E. C., Boorjian, S. A., Frank, I., Schoenberg, M. P., … Daneshmand, S. (2019). Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 37(1), 48–56. -
IMPLEMENTATION OF A REDUCED OPIOID UTILIZATION PROTOCOL FOR RADICAL CYSTECTOMY
Greenberg, D., Kee, J., Stevenson, K., Van Zyl, E., Dugala, A., Prado, K., … Shah, J. (2019). IMPLEMENTATION OF A REDUCED OPIOID UTILIZATION PROTOCOL FOR RADICAL CYSTECTOMY. JOURNAL OF UROLOGY, 201(4), E1196–E1197. -
Predictors of Recurrence, Progression-Free and Overall Survival Following Open Versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Follow-Up.
Venkatramani, V., Reis, I. M., Castle, E. P., Gonzalgo, M. L., Woods, M. E., Svatek, R. S., … Parekh, D. J. (2019). Predictors of Recurrence, Progression-Free and Overall Survival Following Open Versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Follow-Up. The Journal of Urology, 101097JU0000000000000565. -
Implementation of a Reduced Opioid Utilization Protocol for Radical Cystectomy
Greenberg, D. R., Kee, J. R., Stevenson, K., Van Zyl, E., Dugala, A., Prado, K., … Shah, J. B. (2020). Implementation of a Reduced Opioid Utilization Protocol for Radical Cystectomy. BLADDER CANCER, 6(1), 33–42. -
Co-Manifestations of Genital Neurofibromatosis in a Patient with Neurofibromatosis Type 1.
Ku, S., Balasubramanian, A., Kao, C.-S., Eisenberg, M. L., & Skinner, E. C. (2020). Co-Manifestations of Genital Neurofibromatosis in a Patient with Neurofibromatosis Type 1. Urology. -
Development of robust artificial neural networks for prediction of 5-year survival in bladder cancer.
Bhambhvani, H. P., Zamora, A., Shkolyar, E., Prado, K., Greenberg, D. R., Kasman, A. M., … Shah, J. B. (2020). Development of robust artificial neural networks for prediction of 5-year survival in bladder cancer. Urologic Oncology. -
MANAGEMENT OF VARIANT HISTOLOGY IN NON-MUSCLE INVASIVE BLADDER CANCER
Prado, K., Greenberg, D., Zhang, C., Sun, A., & Skinner, E. (2020). MANAGEMENT OF VARIANT HISTOLOGY IN NON-MUSCLE INVASIVE BLADDER CANCER. JOURNAL OF UROLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Women Leaders in Academic Urology: The Views of Department Chairs.
Huen, K. H., Lee, C. T., Skinner, E. C., Terris, M. K., Kobashi, K. C., Bennett, C. J., & Bergman, J. (2020). Women Leaders in Academic Urology: The Views of Department Chairs. Urology. -
Bupivacaine local anesthetic to decrease opioid requirements after radical cystectomy: Does formulation matter?
Schmidt, B., Bhambhvani, H. P., Greenberg, D. R., Prado, K., Shafer, S., Thong, A., … Shah, J. B. (2020). Bupivacaine local anesthetic to decrease opioid requirements after radical cystectomy: Does formulation matter? Urologic Oncology. -
Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: results from a retrospective single-institution cohort analysis.
Del Giudice, F., Busetto, G. M., Gross, M. S., Maggi, M., Sciarra, A., Salciccia, S., … De Berardinis, E. (2021). Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: results from a retrospective single-institution cohort analysis. Journal of Cancer Research and Clinical Oncology. -
Bladder cancer risk stratification using a urinary mRNA biomarker panel - A path towards cystoscopy triaging.
Shkolyar, E., Zhao, Q., Mach, K. E., Teslovich, N. C., Lee, T. J., Cox, S., … Liao, J. C. (2021). Bladder cancer risk stratification using a urinary mRNA biomarker panel - A path towards cystoscopy triaging. Urologic Oncology. -
SEMS trial: Result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma.
Daneshmand, S., Cary, C., Masterson, T. A., Einhorn, L., Boorjian, S. A., Kollmannsberger, C. K., … Hu, B. (2021). SEMS trial: Result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
EFFICACY OF THREE BCG STRAINS (CONNAUGHT, TICE AND RIVM) WITH OR WITHOUT SECONDARY RESECTION (RE-TUR) FOR INTERMEDIATE/HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCERS: RESULTS FROM A RETROSPECTIVE SINGLE-INSTITUTION COHORT ANALYSIS
Del Giudice, F., Busetto, G. M., Maggi, M., Sciarra, A., Salciccia, S., Falagario, U., … De Berardinis, E. (2021). EFFICACY OF THREE BCG STRAINS (CONNAUGHT, TICE AND RIVM) WITH OR WITHOUT SECONDARY RESECTION (RE-TUR) FOR INTERMEDIATE/HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCERS: RESULTS FROM A RETROSPECTIVE SINGLE-INSTITUTION COHORT ANALYSIS. JOURNAL OF UROLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer.
Schmidt, B., Velaer, K. N., Thomas, I.-C., Ganesan, C., Song, S., Pao, A. C., … Leppert, J. T. (1800). Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer. European Urology Open Science, 35, 29–36. -
Atezolizumab (atezo) with or without Bacille Calmette-Guerin (BCG) in patients (pts) with high-risk nonmuscle-invasive bladder cancer (NMIBC): Results from a phase Ib/II study.
Hahn, N. M., Steinberg, G. D., Stratton, K. L., Kopp, R. P., Sankin, A., Skinner, E. C., … Inman, B. A. (2022). Atezolizumab (atezo) with or without Bacille Calmette-Guerin (BCG) in patients (pts) with high-risk nonmuscle-invasive bladder cancer (NMIBC): Results from a phase Ib/II study. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Editorial Commentary on A Call to Action: The Case for Surgical Log Credit for International Rotations and Further Action by the Academic Urology Leadership. Not So Fast!
Skinner, E. C. (2022). Editorial Commentary on A Call to Action: The Case for Surgical Log Credit for International Rotations and Further Action by the Academic Urology Leadership. Not So Fast! UROLOGY PRACTICE, 9(4), 273–274.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer »
- Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial »
- S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer »
- ADAPT-BLADDER: Modern Immunotherapy in BCG-Relapsing Urothelial Carcinoma of the Bladder »
- Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants »
- Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions »
- S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer »
- Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma »
Practice Locations
Urologic Cancer Program in Palo Alto Palo Alto, CA
Palo Alto, CAUrologic Cancer Program in Palo Alto
875 Blake Wilbur Drive
Palo Alto , CA 94304
Make An Appointment More Clinic Information » Getting Here »Patient Reviews
(377 reviews)
View More »
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday – Friday, 8 a.m. – 5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

- Send referrals online
- View referral status
- Access medical records